UK markets closed

Quince Therapeutics, Inc. (QNCX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.0600-0.0700 (-6.19%)
At close: 04:00PM EDT
1.0500 -0.01 (-0.94%)
After hours: 04:43PM EDT

Quince Therapeutics, Inc.

601 Gateway Blvd
Ste 1250
South San Francisco, CA 94080
United States
415 910 5717
https://www.quincetx.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees21

Key executives

NameTitlePayExercisedYear born
Dr. Dirk Thye M.D.CEO & Director681.36kN/A1970
Mr. Brendan Hannah M.B.A.Principal Financial Officer, Principal Accounting Officer, Chief Business Officer & COO504.34kN/A1986
Dr. Charles S. Ryan J.D., Ph.D.PresidentN/AN/A1964
Dr. Guenter R. Janhofer M.D., Ph.D.Chief Scientific OfficerN/AN/AN/A
Ms. Stacy RoughanVice President of Corporate Communications & Investor RelationsN/AN/AN/A
Ms. Mary Ellen SillivosVice President of Human ResourcesN/AN/AN/A
Dr. Stewart A. Low Ph.D.Head of DiscoveryN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Quince Therapeutics, Inc., a preclinical stage biopharmaceutical company, develops precision therapeutics for debilitating and rare diseases. Its lead compound is NOV004, a systemically administered bone anabolic peptide engineered to target and concentrate at bone fracture sites. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.

Corporate governance

Quince Therapeutics, Inc.’s ISS governance QualityScore as of 1 March 2024 is 9. The pillar scores are Audit: 7; Board: 5; Shareholder rights: 10; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.